TY - JOUR KW - BCG Vaccine KW - Humans KW - Immune Tolerance KW - Immunotherapy KW - leprosy KW - Lymphocyte Activation KW - Mycobacterium leprae KW - Skin Tests KW - T-Lymphocytes, Regulatory AU - Rada E M AU - Convit J AU - Ulrich M AU - Gallinotto M E AU - Aranzazu N AB -

Suppressor reactivity was studied in a group of leprosy patients before and after immunotherapy with a mixture of Mycobacterium leprae and BCG. The treatment increases the responses in lymphocyte transformation tests to levels which are comparable to those observed in BT-TT patients and reduces suppressor activity. The soluble extract of M. leprae appears to be more sensitive than purified intact bacilli in the lymphocyte transformation tests, but this preparation did not induce suppressor reactivity with the regularity observed when using a Dharmendra preparation.

BT - International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association C1 - http://www.ncbi.nlm.nih.gov/pubmed/2963084?dopt=Abstract DA - 1987 Dec IS - 4 J2 - Int. J. Lepr. Other Mycobact. Dis. LA - eng N2 -

Suppressor reactivity was studied in a group of leprosy patients before and after immunotherapy with a mixture of Mycobacterium leprae and BCG. The treatment increases the responses in lymphocyte transformation tests to levels which are comparable to those observed in BT-TT patients and reduces suppressor activity. The soluble extract of M. leprae appears to be more sensitive than purified intact bacilli in the lymphocyte transformation tests, but this preparation did not induce suppressor reactivity with the regularity observed when using a Dharmendra preparation.

PY - 1987 SP - 646 EP - 50 T2 - International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association TI - Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. VL - 55 SN - 0148-916X ER -